famotidine has been researched along with Disease in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Famotidine is a potent histamine H2-receptor antagonist widely used in the treatment and prevention of peptic ulcer disease." | 4.78 | Clinical pharmacokinetics of famotidine. ( Echizen, H; Ishizaki, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Echizen, H | 1 |
| Ishizaki, T | 1 |
1 review available for famotidine and Disease
| Article | Year |
|---|---|
Clinical pharmacokinetics of famotidine.
Topics: Aging; Disease; Dose-Response Relationship, Drug; Drug Interactions; Famotidine; Hemofiltration; Hum | 1991 |